Medicinski fakultet, Katedra za farmaciju
Organization name
Medicinski fakultet, Katedra za farmaciju
Parent OrgUnit
City
Novi Sad
Country
Serbia
OrgUnit's Researchers publications
(Dept/Workgroup Publication)
Type
Fulltext
Results 1-20 of 20 (Search time: 0.003 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 2018 | 12-oxo chenodeoxycholic acid potentiates doxorubicin-induced oxidative stress through Nrf2 axis in breast adenocarcinoma cells | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Jasmina Katanić ; Iva Barjaktarović ; Momir Mikov |
| 2 | 2017 | Antioxidant effects of ursodeoxycholic acid in doxorubicin-induced oxidative hepatocyte injury | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Velibor Vasović ; Momir Mikov |
| 3 | 1-Jul-2010 | Antioxidant properties of fullerenol C60(OH)24 in rat kidneys, testes, and lungs treated with doxorubicin | Branislava Srđenović Čonić ; Vukosava Milić-Torres; Nevena Grujić Letić ; Karmen Stankov ; Aleksandar Đorđević ; Velibor Vasović |
| 4 | 2018 | Bile acid potentiates apoptosis of human breast adenocarcinoma cells induced by doxorubicin | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Bogdanović G; Vesna Kojić ; Momir Mikov |
| 5 | 8-Nov-2018 | Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Maja Đanić ; Bojan Stanimirov ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 6 | 1-Jan-2014 | Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia) | Nataša Vučinić ; Đan Igor ; Edita Stokić ; Biljana Božin ; Dragana Obreht; Karmen Stankov ; Mihajla Đan (Davidović) |
| 7 | 1-Jan-2019 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Mikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H. |
| 8 | 2016 | The effects of usodeoxycholic acid on cytotoxic activity and proapoptotic potential of doxorubicin in MCF-7 cell line | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Vesna Kojić ; Iva Barjaktarović ; Momir Mikov |
| 9 | 2019 | In silico alternatives to animal testing: state of the art | Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Maja Đanić ; Bojan Stanimirov ; Mladena Lalić-Popović ; Momir Mikov |
| 10 | 1-Jan-2019 | In silico discovery of resveratrol analogues as potential agents in treatment of metabolic disorders | Nebojša Pavlović ; Maja Đanić ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Mladena Lalić-Popović ; Momir Mikov |
| 11 | 2018 | In vivo effects of ursodeoxycholic acid on doxorubicin-induced oxidative injury of hepatocyte | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Svetlana Goločorbin-Kon ; Momir Mikov |
| 12 | 1-Jan-2017 | The LRP1 gene polymorphism is associated with increased risk of metabolic syndrome prevalence in the Serbian population | Nataša Vučinić ; Edita Stokić ; Đan Igor ; Dragana Obreht; Nevena Veličković ; Karmen Stankov ; Mihajla Đan (Davidović) |
| 13 | 2018 | Non-toxic bile acids as pharmaceutical excipients may alter pharmacological activity of antitumor drug vorinostat | Nebojša Pavlović ; Karmen Stankov ; Svetlana Goločorbin-Kon ; Mladena Lalić-Popović ; Bojan Stanimirov ; Maja Đanić ; Momir Mikov |
| 14 | 1-Jan-2018 | Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov |
| 15 | 1-Dec-2019 | Possible synergistic effect of apoE and LRP1 genotypes on metabolic syndrome development in Serbian patients | Nataša Vučinić ; Karmen Stankov ; Mihajla Đan (Davidović) ; Iva Barjaktarović ; Edita Stokić ; Ljiljana Strajnić; Dragana Obreht; Đan Igor |
| 16 | 1-Jun-2018 | Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 17 | 1-Dec-2012 | Probiotics - Interactions with Bile Acids and Impact on Cholesterol Metabolism | Nebojša Pavlović ; Karmen Stankov ; Momir Mikov |
| 18 | 1-Dec-2017 | The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes | Momir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
| 19 | 2015 | Size distribution of fullerenol nanoparticles in cell culture medium and their influence on antioxidative enzymes in Chinese hamster ovary cells | Srdjenovic Branislava; Marija Slavić; Stankov Karmen ; Kladar Nebojša ; Jović Danica ; Seke Mariana; Bogdanović Višnja |
| 20 | 2017 | Ursodeoxycholic acid sensitizes human breast adenocarcinoma cells to doxorubicin-induced apoptosis | Bojan Stanimirov ; Karmen Stankov ; Nebojša Pavlović ; Maja Đanić ; Velibor Vasović ; Momir Mikov |